Literature DB >> 27450199

Diagnostic delay in axial spondyloarthritis: A cross-sectional study of 432 patients.

Vanina Masson Behar1, Maxime Dougados2, Adrien Etcheto2, Sarah Kreis3, Stéphanie Fabre4, Christophe Hudry2, Sabrina Dadoun3, Christopher Rein3, Edouard Pertuiset5, Bruno Fautrel3, Laure Gossec6.   

Abstract

OBJECTIVES: The diagnostic delay of axial spondyloarthritis (axSpA) is usually reported to be more than seven years but may have decreased recently. The objective was to quantify the diagnostic delay in patients with axSpA in France and to explore its associated factors.
METHODS: Two cross-sectional observational studies included consecutively patients with axSpA (according to both ASAS criteria and rheumatologist expert opinion). Diagnostic delay was defined as the time interval from the date of first symptoms to the date of diagnosis. Potential predictive factors of diagnostic delay analyzed by multiple linear regression were demographic factors, HLA B27 status, year of diagnosis, clinical presentation and sacroiliitis on MRI or radiography.
RESULTS: In all, 432 patients were analyzed: the mean age at diagnosis was 34.2 (standard deviation, 12.5) years, the mean disease duration at the time of the assessment was 11.4 (10.4) years. In all, 66.7% were HLA B27 positive, and 70.2% had radiographic sacroiliitis. The mean diagnostic delay was 4.9 (6.3) years, with a median of 2.0 years (interquartile range, 1-7; range: 0-43). In multivariable analysis, factors independently associated with a longer diagnostic delay were: higher age at diagnosis (beta=0.13; P<0.001), less frequent peripheral arthritis or dactylitis (beta=-1.69; P=0.005), and more frequent entheseal pain (beta=1.46; P=0.015).
CONCLUSION: The median diagnostic delay was 2 years indicating diagnostic delay may be for most patients shorter than previously reported. A more "typical" SpA clinical presentation was associated with a shorter diagnostic delay, whereas sacroiliitis and HLA B27 positivity were not associated with this delay.
Copyright © 2016 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Delay; Diagnosis; Spondyloarthritis

Mesh:

Year:  2016        PMID: 27450199     DOI: 10.1016/j.jbspin.2016.06.005

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  14 in total

Review 1.  Unmet Needs in Axial Spondyloarthritis.

Authors:  Ennio Lubrano; Antonia De Socio; Fabio Massimo Perrotta
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

2.  Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice.

Authors:  Raquel Almodóvar; Ángel Bueno; Enrique Batlle; Emma Beltrán-Catalán; Daniel Bernabeu; Carmen Castro Copete; Angela Cepero; Concha Crespo; Fernando Díez; Cristina Fernández-Carballido; Fran García Lorente; Angel Gil De Miguel; Xavier Juanola; Luis Linares; Rafael Montero Pérez-Barquero; Carmen Castro; Manuel José Moreno Ramos; Mireia Moreno; Victoria Navarro-Compán; Christopher Pack; Carlos Quiles; Maite Veintemillas; Pedro Zarco
Journal:  Rheumatol Int       Date:  2019-09-18       Impact factor: 2.631

3.  The usefulness of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) sequences visual assessment in the early diagnosis of axial spondyloarthritis.

Authors:  Iwona Kucybała; Szymon Ciuk; Andrzej Urbanik; Wadim Wojciechowski
Journal:  Rheumatol Int       Date:  2019-07-10       Impact factor: 2.631

4.  Fever as an initial manifestation of spondyloarthritis: A retrospective study.

Authors:  Se Jin Byun; William Han Bae; Seung Min Jung; Sang-Won Lee; Yong-Beom Park; Jason Jungsik Song
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

5.  Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort.

Authors:  Janneke J de Winter; Marleen G van de Sande; Niklas Baerlecken; Inger Berg; Roberta Ramonda; Désirée van der Heijde; Floris A van Gaalen; Torsten Witte; Dominique L Baeten
Journal:  Arthritis Res Ther       Date:  2018-03-01       Impact factor: 5.156

6.  Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE.

Authors:  Robert Landewé; Désirée van der Heijde; Maxime Dougados; Xenofon Baraliakos; Filip Van den Bosch; Karl Gaffney; Lars Bauer; Bengt Hoepken; Natasha de Peyrecave; Karen Thomas; Lianne S Gensler
Journal:  Rheumatol Ther       Date:  2020-06-11

7.  Challenges to conquer from the gender perspective in medicine: The case of spondyloarthritis.

Authors:  Vega Jovani; Mar Blasco-Blasco; Eliseo Pascual; M Teresa Ruiz-Cantero
Journal:  PLoS One       Date:  2018-10-12       Impact factor: 3.240

8.  Evaluation of the performances of 'typical' imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study.

Authors:  Anna Molto; Laure Gossec; Marie-Martine Lefèvre-Colau; Violaine Foltz; Romain Beaufort; Jean-Denis Laredo; Pascal Richette; Philippe Dieude; Philippe Goupille; Antoine Feydy; Maxime Dougados
Journal:  RMD Open       Date:  2019-05-28

9.  Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence.

Authors:  Nelly R Ziade; Iyad Mallak; Georges Merheb; Pierre Ghorra; Niklas Baerlecken; Torsten Witte; Xenofon Baraliakos
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

10.  Axial spondyloarthritis 10 years on: still looking for the lost tribe.

Authors:  Rosemarie Barnett; Thomas Ingram; Raj Sengupta
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.